Hi everyone, I am fed up with just sitting around

New Post Public Reply Private Reply Replies (2) Message Board
Zolis_onkel
286
Hi everyone,

I am fed up with just sitting around waiting for GNBT to finally release some news. So I have just sent the following email to Todd Falls, should I receive a meaningful reply, that is worth posting here, I will let you know as well:

Hi Todd,

the silence that we, GNBT's shareholders, seems get from the company gets more and more defeaning. While the entire world is more and more dragged into this crisis, there are a whole bunch of companies that publicly announce that they are working on a cure, vaccine or quick test kit to help fight this "invisible enemy" and - as icing on the cake -  to even profit financially from it. GNBT not so much, as it seems. 
Every time any company makes such an announcement the share price seems to skyrocket. Now one of your last longer PRs, from 2 weeks ago!!!, claimed that GNBT's Ii-Key technology is the best in class, full snythetical, and thus very quickly adaptable to the current virus, has already been tested in humans and can be produced in large quantaties in a short period of time. This all sounds as if this is the perfect answer to the currently ongoing crisis. The only thing that is missing is the related announcements from you about the current status. I honestly have no clue why that is, and would really like to get an answer from you for.
The next thing that I do not understand is, why we have to learn from Joe's FB account that he traveled to DC, and have to assume that this was not a sightseeing trip? A picture, which is no longer publicly available, showed Joe and Dr. Eric von Hofe in the lobby of a building that we assumed to be the HHS head quarters. This got a whole bunch of us overly excited, however, until now, more than a week later, we have heard nothing from you in this regard? This has all of us very much confused.
All in all, I honestly have no understanding about the lack of communication that is currently going on. While the entire world is in crisis, stock markets are in limbo all over the world and everybody is desperately waiting for good news, in regards to a cure, GNBT could be in a position to provide what mankind requires the most (a vaccine) and in particular benefit substantially from this crisis. Yet, there is deafening silence from your side for 2 weeks that feel almost like an eternity to all of us, as we watch the PPS drop further and further.
Why are we not hearing any updates on the vaccine development for your chinese partners? In fact, why was there no public announcement that the previously announced trip to China for the signing ceremony was cancelled, but still the contract is in full effect? This still leads to a lot of confusion among the GNBT shareholders that I regularly exchange messages with on various message boards!!!
What is NGDx doing in regards to creating a COVID-19 test kit? Nothing? If yes, why? If no, why are we not hearing anything about it?
Besides all of the COVID-19 related stuff. The dividend was paid out more than 5 weeks ago, and prior to that pay date, we were told that A LOT OF things are held up by the not paid dividend and that things would start moving quickly once the dividend is paid. Well, this is 5 weeks ago now and there are no updates on the S-1s, the funding being made available, the closure of the AltuCell deal, the IPO of NGIO or the uplisting of GNBT.
I assume, or at least hope, that there is a lot going on that has just not been publicly disclosed, but WHY IN THIS WORLD do you leave all of us so much in the dark about the important stuff, and then waste time and money to announce that GNBT is sponsoring a charity event?
Or just looking at the last PR. When looking closely into that, this sounds like AMAZING news, but only to those as knowledgeable about GNBT as the few "hardcore" investors, such that I am considering myself to be. But to the larger public, the way you have written this PR, it does not paint the exciting picture that this news really represents, because - once again - the hard fiancial facts are missing. It is good to read that Anthony Dolisi calls this an "exciting day" for Olaregen, and I tend to agree, but the excitement does not really spread, as long as this news lacks the information that this has the potential to quickly lead to 7- or 8 figure numbers is in sales and revenue. THIS IS what I, as a GNBT shareholder, want to read and would get really excited about!!!

To make a long story short, and I know that you are not able to answer all my questions personally to me, but please update all of us on ALL THAT IS SURELY GOING ON right now, behind closed doors and let us know all where the company of GNBT, we all own our specific share of, is currently at!

Thanks a lot in advance.

Best regards from Germany

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

DKS Lawsuit Deadline: Investors Must Act by Nov 3, 2026

Updated Category News Views 78

Clock's Ticking for DICK'S Investors If you've got money tied up in DICK'S Sporting Goods—bought between September 8, 2025, and August 24, 2026—listen up. There's a class action lawsuit aiming to recover some of what might've slipped through your fingers. Come November 3, 2026, the door slams shut on your chance to get involved. What's the Beef? Apparently, DICK'S had...

Continue Reading
ModelBest & OpenBMB Unveil Open-Source OCR Models

Updated Category News Views 132

A New Frontier in Document Parsing Just when you thought document parsing couldn't get any more advanced, ModelBest and OpenBMB come along with a game-changing release: the MiniCPM-OCR series. This duo of dynamite models, MiniCPM-OCR 1.0 and Jev, is all about taking the efficiency and performance expectations for open-source OCR models up a couple of notches. If you're an...

Continue Reading
HanAll F&B Pioneers New Path for Domestic Rice Noodles

Updated Category News Views 227

New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...

Continue Reading
OlloBot's Emotional AI Robots Connect Beyond Tasks

Updated Category News Views 20

OlloBot Eyes Emotional Bonds, Not Just Robotics Power Is it just me, or is OlloBot onto something deep with their emotional AI companions? They've set a course that might just redefine how we perceive home robotics. At IFA Berlin 2026, they didn't just strut their technical stuff. Nope, they took it beyond gears and gadgets, turning heads with a robot that does more than...

Continue Reading
UBCF Strikes Big in Times Square with New Billboards

Updated Category News Views 142

From the Shadows to the Spotlight Ever seen someone step up to the plate and knock it out of the park? That's what the United Breast Cancer Foundation (UBCF) is doing by plastering their mission right across Times Square. Talk about grabbing the bull by the horns, eh? With not one, but two billboards now gracing one of the globe's most iconic public spaces, they've...

Continue Reading
Zhimeng Biopharma Hits Key Milestone in ALS Drug Trial

Updated Category News Views 183

Pivotal Point for Zhimeng's ALS Efforts Folks, get this—Zhimeng Biopharma's rolling out the big guns here with a significant step forward in their ALS treatment quest. This company just wrapped up patient enrollment for their next-gen ALS drug, CB03-154. We're talking about 255 patients now on board for a Phase 2/3 trial. The ground's shaking a bit because this...

Continue Reading
Race for Life Rescue Logs 200 Flights for Shelter Pets

Updated Category News Views 127

Airborne Lifelines for Vulnerable Animals Ever picture an airplane filled with hope? Well, Race for Life Rescue isn't just carting metal through the sky; they're lifting spirits, one furry passenger at a time. Picture this: a nonprofit turning a clunky Beechcraft into a flying ark, whisking away 112 at-risk pets from Louisiana to fresh starts in the Northeast. And guess...

Continue Reading
Bass Angler Matt Robertson Reels in Record $1.25M Prize

Updated Category News Views 91

A New Era for Bass Fishing Payouts Who would have thought we'd see the day when bass fishing turned out to be as lucrative as a Wall Street handshake? But here we are, with Matt Robertson hauling in a whopping $1.25 million prize at World Bass Enterprises' first "The Champions" Tournament. We're not talking chump change here—this is the real deal in a sport often...

Continue Reading
Rural AI Skills Gap Uncovered: Challenges and Solutions

Updated Category News Views 86

Rural Workers Face Distinct AI Challenges Ah, life in the countryside might sound serene, but when it comes to keeping up with AI, rural folks aren't sipping lemonade and waiting on a windfall. The newly unveiled paper from the University of Phoenix College of Doctoral Studies shines a floodlight on some hefty challenges facing rural communities—particularly around...

Continue Reading
NABEP's Strategic Push: 41 Rigs to Bolster Output

Updated Category News Views 208

On The Ground: NABEP's Expanding Venezuelan Presence Think of oil production as a high-stakes poker game where each drill and rig is a well-placed bet. North American Blue Energy Partners (NABEP) is going all in on Venezuela, boosting their rig fleet and pushing production capacity to new heights. Set your sights on November when NABEP's in-country fleet will hit 41 rigs...

Continue Reading

Top 5 Most Recently Viewed Articles

Hydrolix Achieves Recognition as Top Akamai Partner in North America

Updated Category News Views 230

Hydrolix's Recognition as a Leading Partner Hydrolix, renowned for revolutionizing log data economics, has received significant accolades for its contributions as a trusted partner in the tech landscape. The company’s streaming data lake platform has been recognized by Akamai as the North America Qualified Computing Partner of the Year. This prestigious award highlights...

Continue Reading
MicroStrategy Stock's Unexpected Decline Amid Positive Crypto News

Updated Category News Views 235

MicroStrategy Stock Dynamics MicroStrategy Inc Class A (MSTR), recognized for its substantial Bitcoin holdings, encountered a surprising decline in its stock price, falling by approximately 5% during a period of optimism in the cryptocurrency market. This downturn occurred despite recent significant legislative advancements that promise a brighter future for digital...

Continue Reading
Sepsis Diagnostics Market Growth: Innovations and Trends Ahead

Updated Category News Views 180

Sepsis Diagnostics Market Growth: Innovations and Trends Ahead The Sepsis Diagnostics market is witnessing a remarkable transformation fueled by an urgent need for enhanced awareness, prevention strategies, and groundbreaking technological innovations. This sector, expected to grow from USD 1.2 billion to an impressive USD 2.5 billion, reflects a compound annual growth...

Continue Reading
DocGo Stock Reaches New Heights Amid Surge in Healthcare Demand

Updated Category News Views 219

DocGo Stock Soars to New Heights In an impressive display of market confidence, DocGo (DCGO) stock has soared to a 52-week high, reaching $4.88, fueled by a remarkable 30% revenue growth year-over-year. This peak is reflective of a significant surge in investor interest, coinciding with an increasing demand for healthcare services and mobile health solutions. Over the...

Continue Reading
Earnings Insights for Essent Group: What Investors Should Know

Updated Category News Views 151

Essent Group's Upcoming Earnings Release Essent Group (NYSE: ESNT) is gearing up to share its quarterly earnings results, and investors are keenly anticipating the outcomes. The earnings report is expected to shed light on the company's financial health and future projections. Expected Earnings Performance Market analysts are forecasting that the Essent Group will report...

Continue Reading